Development of criteria for ovarian preservation in cervical cancer patients treated with radical surgery with or without neoadjuvant chemotherapy: A multicenter retrospective study and meta-analysis

Annals of Surgical Oncology

Volumn 20, Issue 3, 2013, Pages 881-890

  Hu, Ting ^a   Wu, Li ^b   Xing, Hui ^a   Yang, Ru ^a   Li, Xiong ^a   Huang, Kecheng ^a   Jia, Yao ^a   Zhang, Qinghua ^a   Chen, Zhilan ^a   Wang, Shaoshuai ^a   Liu, Dan ^a   Han, Xiaobing ^d   Lin, Zhongqiu ^e   Qu, Pengpeng ^f   Cai, Hongbing ^g   Song, Xiaojie ^h   Tian, Xiaoyu ⁱ   Wang, Hui ^a   Wang, Shixuan ^a   Xie, Xing ^c   Li, Shuang ^a   Ma, Ding ^a   more..

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUNAN CANCER HOSPITAL   (China)

^c Women's Reproductive Health Laboratory of Zhejiang Province   (China)

^d MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^e SUN YAT SEN UNIVERSITY   (China)

^f Tianjin Central Obstetrics and Gynecological Hospital   (China)

^g WUHAN UNIVERSITY   (China)

^h Commercial Vocational Hospital ^*  (China)

ⁱ HENAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADENOSQUAMOUS CARCINOMA; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER INVASION; CANCER PATIENT; CANCER SIZE; CANCER STAGING; CANCER SURGERY; FEMALE; HISTOLOGY; HUMAN; HYSTERECTOMY; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; META ANALYSIS; MULTICENTER STUDY; OVARIAN PRESERVATION; OVARY ADENOCARCINOMA; OVARY METASTASIS; PELVIS LYMPHADENECTOMY; RETROSPECTIVE STUDY; RISK FACTOR; SALPINGOOOPHORECTOMY; SMALL CELL CARCINOMA; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER;

ADENOCARCINOMA; ADULT; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; COMBINED MODALITY THERAPY; FEMALE; FERTILITY PRESERVATION; FOLLOW-UP STUDIES; HUMANS; HYSTERECTOMY; LYMPHATIC METASTASIS; META-ANALYSIS AS TOPIC; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS;

EID: 84875222034     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2632-8     Document Type: Article

References (21)

1. A Jemal F Bray MM Center J Ferlay E Ward D Forman 2011 Global cancer statistics CA Cancer J Clin. 61 69 90 21296855 10.3322/caac.20107
2. F Landoni V Zanagnolo L Lovato-Diaz, et al. 2007 Ovarian metastases in early-stage cervical cancer (IA2-IIA): a multicenter retrospective study of 1965 patients (a cooperative task force study) Int J Gynecol Cancer. 17 623 628 17309669 10.1111/j.1525-1438.2006.00854.x 1:STN:280:DC%2BD2s3pt1aiuw%3D%3D
3. M Shimada J Kigawa R Nishimura, et al. 2006 Ovarian metastasis in carcinoma of the uterine cervix Gynecol Oncol. 101 234 237 16300819 10.1016/j.ygyno.2005.10.004
4. R Yamamoto K Okamoto T Yukiharu, et al. 2001 A study of risk factors for ovarian metastases in stage Ib-IIIb cervical carcinoma and analysis of ovarian function after a transposition Gynecol Oncol. 82 312 316 11531285 10.1006/gyno.2001.6277 1:STN:280:DC%2BD3MvovFaitg%3D%3D
5. T Nakanishi K Wakai H Ishikawa, et al. 2001 A comparison of ovarian metastasis between squamous cell carcinoma and adenocarcinoma of the uterine cervix Gynecol Oncol. 82 504 509 11520147 10.1006/gyno.2001.6316 1:STN:280:DC%2BD3Mvnslagsg%3D%3D
6. N Sakuragi N Takeda H Hareyama, et al. 2000 A multivariate analysis of blood vessel and lymph vessel invasion as predictors of ovarian and lymph node metastases in patients with cervical carcinoma Cancer. 88 2578 2583 10861436 10.1002/1097-0142(20000601)88:11<2578::AID-CNCR21>3.0.CO;2-Y 1:STN:280:DC%2BD3cvisFyrtA%3D%3D
7. N Natsume Y Aoki H Kase K Kashima S Sugaya K Tanaka 1999 Ovarian metastasis in stage IB and II cervical adenocarcinoma Gynecol Oncol. 74 255 258 10419741 10.1006/gyno.1999.5442 1:STN:280:DyaK1MzltVentA%3D%3D
8. HS Wu MS Yen CR Lai HT Ng 1997 Ovarian metastasis from cervical carcinoma Int J Gynaecol Obstet. 57 173 178 9184955 10.1016/S0020-7292(97)02848-8 1:STN:280:DyaK2szivVCitQ%3D%3D
9. MJ Kim HH Chung JW Kim NH Park YS Song SB Kang 2008 Uterine corpus involvement as well as histologic type is an independent predictor of ovarian metastasis in uterine cervical cancer J Gynecol Oncol. 19 181 184 19471574 10.3802/jgo.2008.19.3.181
10. T Thigpen H Shingleton H Homesley L Lagasse J Blessing 1981 Cis-platinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix: a phase II study of the gynecologic oncology group Cancer. 48 899 903 7196794 10.1002/1097-0142(19810815)48:4<899::AID-CNCR2820480406>3.0.CO;2-6 1:STN:280:DyaL38%2FgtFygtg%3D%3D
11. HS Kim JY Kim NH Park, et al. 2010 Matched-case comparison for the efficacy of neoadjuvant chemotherapy before surgery in FIGO stage IB1-IIA cervical cancer Gynecol Oncol. 119 217 224 20705335 10.1016/j.ygyno.2010.06.017
12. L Rydzewska J Tierney CL Vale PR Symonds 2010 Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancer Cochrane Database Syst Rev. 1 CD007406 20091632
13. Q Wang JJ Koval CA Mills K-ID Lee 2007 Determination of the selection statistics and best significance level in backward stepwise logistic regression Commun Stat Simulat Comput. 37 62 72 10.1080/03610910701723625 1:CAS:528:DC%2BD2sXmslKmsLc%3D
14. M Tabata K Ichinoe N Sakuragi Y Shiina T Yamaguchi Y Mabuchi 1987 Incidence of ovarian metastasis in patients with cancer of the uterine cervix Gynecol Oncol. 28 255 261 3678976 10.1016/0090-8258(87)90170-3 1:STN:280:DyaL1c%2Fls1GhtQ%3D%3D
15. N Toki N Tsukamoto T Kaku, et al. 1991 Microscopic ovarian metastasis of the uterine cervical cancer Gynecol Oncol. 41 46 51 2026359 10.1016/0090- 8258(91)90253-2 1:STN:280:DyaK3M3isVGgtQ%3D%3D
16. GP Sutton BN Bundy G Delgado, et al. 1992 Ovarian metastases in stage IB carcinoma of the cervix: a gynecologic oncology group study Am J Obstet Gynecol. 166 50 53 1733218 1:STN:280:DyaK387isFeqsA%3D%3D
17. A Gonzalez-Martin L Gonzalez-Cortijo N Carballo, et al. 2008 The current role of neoadjuvant chemotherapy in the management of cervical carcinoma Gynecol Oncol. 110 S36 S40 18586309 10.1016/j.ygyno.2008.05.012
18. Hu T, Li S, Chen Y, et al. Matched-case comparison of neoadjuvant chemotherapy in patients with FIGO stage IB1-IIB cervical cancer to establish selection criteria. Eur J Cancer. 2012;48:2353-60.
19. WJ Mann J Chumas T Amalfitano C Westermann B Patsner 1987 Ovarian metastases from stage IB adenocarcinoma of the cervix Cancer. 60 1123 1126 3607729 10.1002/1097-0142(19870901)60:5<1123::AID-CNCR2820600534>3.0.CO;2- P 1:STN:280:DyaL2s3ntlWisw%3D%3D
20. J Liu Y Li S Li, et al. 2010 Clinicopathological features and prognosis of small cell carcinoma of the cervix J Huazhong Univ Sci Technol Med Sci. 30 626 630 21063846 10.1007/s11596-010-0554-x
21. RH Young DJ Gersell LM Roth RE Scully 1993 Ovarian metastases from cervical carcinomas other than pure adenocarcinomas. A report of 12 cases Cancer. 71 407 418 8380753 10.1002/1097-0142(19930115)71:2<407::AID- CNCR2820710223>3.0.CO;2-G 1:STN:280:DyaK3s7jslWrug%3D%3D